July 16, 2026

‍

UnitedHealth Group Incorporated (NYSE: UNH) reported second-quarter 2026 results above expectations, supported by higher revenue, stronger adjusted earnings, improved medical cost performance, and raised full-year guidance.
‍

UnitedHealth Group is a health care and insurance company that operates through UnitedHealthcare, which provides health benefits, and Optum, which provides care delivery, pharmacy services, data, analytics, and health technology services.
‍

The company reported adjusted EPS of $6.38, above estimates of $4.87, representing a 31.0% earnings surprise. Revenue came in at $112.03 billion, above estimates of $110.05 billion, with revenue growth of 0.4%.

‍

Results Beat Expectations

‍

Second-quarter revenue was $112.0 billion, compared with $111.6 billion a year earlier.
‍

Earnings from operations were $8.0 billion, up from $5.2 billion in the prior-year quarter.
‍

GAAP EPS was $6.04, while adjusted EPS was $6.38.
‍

Net margin was 4.9%.
‍

Cash flow from operations was $11.1 billion, or 1.9 times net income.

‍

Medical Cost Ratio Improved

‍

UnitedHealth’s medical care ratio was 86.7%, compared with 89.4% in the prior-year quarter.
‍

The company said the improvement reflected product design changes, better medical management, pricing discipline, member mix, and $860 million of net favorable prior-period development.
‍

The operating cost ratio was 12.7%, compared with 12.3% a year earlier, reflecting investments in technology, operations, infrastructure, artificial intelligence, care delivery, consumer experience, and community support.

‍

UnitedHealthcare and Optum Performance

‍

UnitedHealthcare reported revenue of $86.0 billion and earnings from operations of $3.9 billion.
‍

The segment served 48.5 million consumers, down 525,000 sequentially.
‍

UnitedHealthcare’s operating margin improved to 4.6%, compared with 2.4% in the prior-year quarter.
‍

Optum generated revenue of $65.7 billion and earnings from operations of $4.0 billion.
‍

Optum Health revenue declined 5% year-over-year due to fewer value-based care patients served, but operating earnings improved to $1.2 billion.
‍

Optum Insight revenue was $5.4 billion, while Optum Rx revenue was $38.3 billion.

‍

Guidance Raised

‍

UnitedHealth raised its full-year 2026 earnings outlook.
‍

The company now expects GAAP EPS of $18.45 to $18.95.
‍

Adjusted EPS is expected to range from $19.50 to $20.00.
‍

UnitedHealth also expects full-year cash flow from operations of about $24.0 billion and share repurchases of at least $5.0 billion.
‍

The company said the updated outlook reflects performance year-to-date and an improved view for the rest of 2026.

‍

Market Focus

‍

Investors are likely watching the medical care ratio, adjusted EPS guidance, Optum margin improvement, UnitedHealthcare membership trends, Medicare Advantage pressure, Medicaid eligibility impacts, cash flow, debt-to-capital levels, and share repurchases.
‍

The earnings beat was positive, but the key signal was the raised full-year outlook after several quarters of pressure around medical costs and health care utilization.

‍

The Bigger Picture

‍

UnitedHealth delivered a stronger quarter than expected.
‍

Revenue edged higher, adjusted EPS beat estimates, earnings from operations increased, and the medical care ratio improved from last year. The company also raised full-year EPS guidance and increased its expected share repurchases.
‍

The key question is whether UnitedHealth can keep medical costs under control while stabilizing membership trends across Medicare Advantage, Medicaid, and employer plans.
‍

Platforms like LevelFields track earnings beats, layoffs, dividend increases, leadership changes, dividend updates, and stock reactions together, helping investors identify when health care stocks are moving on real operating improvement or cost pressure.